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This study investigated the cytotoxicity of 55 species of plants. Each plant was rated as medicinal, or nonmedicinal based on the
existing literature. About 79% of the medicinal plants showed some cytotoxicity, while 75% of the nonmedicinal plants showed
bioactivity. It appears that Asteraceae, Labiatae, Pinaceae, and Chenopodiaceae were particularly active against human cervical
cancer cells. Based on the literature, only three of the 55 plants have been signiﬁcantly investigated for cytotoxicity. It is clear that
there is much toxicological work yet to be done with both medicinal and nonmedicinal plants.
1.Introduction
There is a one-in-four chance that a drug used from any
pharmacy has an active ingredient derived from a plant [1].
Indeed, the international consumer market for medicinal
herbs and botanicals is estimated to be at about US $18
billion [2]. Hence, in our technological age, plants continue
to play a signiﬁcant role both medically and economically.
Even the most ancient written records of human civiliza-
tiontellofhumansusingplantsineverydaylife.Forcenturies
plants have been used to feed, clothe, and heal families.
Examples of medicine that contains plant derivatives include
aspirin, used for pain relief and inﬂammation reduction;
physostigmine and pilocarpine, used for glaucoma control;
quinidine, which has saved the lives of many heart attack
victims.
The principal goal of this study was to determine if
extracts from selected medicinal and nonmedicinal plants
were cytotoxic; often, the diﬀerence between a therapeutic
andatoxicextractorcompoundissimplythedoselevel.Our
hope is that these survey data can be used as early indicators
of some plants that may have therapeutic activity. Moerman
hasdoneextensivescreeningstudiesonavarietyofmedicinal
plants [3]. From his investigation, we selected 55 plants
representing 37 diﬀerent species from 8 families. The four
principal families, Asteraceae, Labiatae, Ranunculaceae, and
Pinaceae, represent the ﬁrst, third, fourth, and ﬁfth families
with the most medicinal species. It was hoped that our data
might show some trends of toxicity within medicinally rich
families.
The toxicity of each extract was determined in both
prokaryotic and eukaryotic cells. Prokaryote cells included
Staphylococcus aureus, a gram-positive cocci responsible for
infections of the skin and respiratory tract, food poisoning,
andtoxicshock;Salmonellacholeraesuis,agram-negativefac-
ultative aerobe responsible for food poisoning; Pseudomonas
aeruginosa, a gram-negative rod that causes infections in
wounds. For the eukaryotic system, HeLa cells, an epithelial
carcinoma of the cervix, were used.
2.MaterialsandMethods
2.1. Plant Extraction
(i) 50g of plant tissue were collected and dried at 45◦C.
(ii) The plant was ground in a Wiley Model no. 4 plant
mill.
(iii) The ground material was then extracted in methanol
for twenty-four hours.
(iv) The samples were ﬁltered in glass-ﬁber ﬁlters ﬁtted
with coarse pore discs, and rotary evaporated down
to 20mL of extract on a Buchi RE111 Rotary
Evaporator.2 Journal of Biomedicine and Biotechnology
2.2. Microbial Bioassay
(i) Twenty-four hours before the assay, each of the three
b a c t e r i aw e r eg r o w ni nac u l t u r et u b ew i t h5m Lo f
tryptic soy broth without dextrose and incubated at
35◦C.
(ii) (14.5cm) Petri dishes were previously prepared with
a coat of Muller Hinton Medium (agar). The cultures
were checked on a spectrophotometer to ensure the
proper growth (20% transmittance at 600nm). A
lawn was then spread in the petri dish. Six 1.4cm
circles of ﬁlter paper were then coated in plant
extract, three with 20μL and three with 30μL, and
placed on the plate. A disk with 20μLo fw a t e r
was added to the plate for a negative control and
to S. aureus, S. choleraesuis, 10μL of Ampicillin
(BBL Sensi-Disc (Becton Dickinson)) was added as a
positive control. The plates were incubated overnight
at 35◦C.
(iii) The plates were then collected the next day and the
zones of inhibition were measured.
2.3. HeLa Assay
(i) HeLacellsweremaintainedandassayedinMEMwith
α modiﬁcation (Sigma M-0894) supplemented with
10% fetal bovine serum, 1mM sodium pyruvate,
1x MEM-nonessential amino acids (Sigma M-7145),
2mM L-glutamine, and gentamicin at 50μg/mL.
(ii) Each extract was dried down and 2mg/mL solutions
were made using 10mM Tris buﬀer at pH 7.4.
(iii) 150μL of a solution of suspended HeLa cells diluted
with 15mL of α-MEM is added to each well of a 96
well plate and incubated overnight at 37◦Ca n d5 %
CO2.
(iv) The next day 75μL, 50μL, 25μLw i t h2 5 μLo fα-
MEM, 12.5μL with 37.5μLo fα-MEM, or 6μLw i t h
44μLo fα-MEM of the 2mg/mL extracts was added
to 9 wells as a control. The prepared plate was
incubated overnight.
(v) The cells were arrested the next morning with 0.4N
perchloric acid. The perchloric acid is removed, and
the cells were stained in 4% sulforhodamine B in
1% acetic acid and then washed in 1% acetic acid.
The dye was allowed to dry and 150μLo f1 0 m M
Tris base unbuﬀered was then added to each well,
and the absorbance of each well was read using a
spectrophotometer at 570nm.
(vi) The percent viability was calculated as the ratio of
absorbance of the treated sample over the average
of the controls. These values were then plotted and
analyzed for a dose response.
3. Results
3.1. Microbial Assay. Of the 55 plants tested, only four,
Pinus monticola, Abies procera, Salvia vaseyi, and Salvia
apiana, inhibited the growth of S. aureus. The remaining
microorganisms were unaﬀected by the extracts. However,
the zones of inhibition were quite small, only about 1cm
each.Theassayisratheracrudetestwhencomparedwiththe
HeLa cell assay. This is understandable because the zone of
inhibitionisdirectlyproportionaltotheconcentrationofthe
biologically active agent and its diﬀusibility, so the possibility
of active compounds not showing a positive response could
be expected if the active ingredients did not diﬀuse. Due to
the screening nature of this procedure and small sample size,
the quantitative analysis of the size of the rings of inhibition
was quite subjective.
3.2. HeLa Cell Assay. T h eL C - 5 0sw e r ec a l c u l a t e df o re a c h
of the samples. Some of the extracts were so toxic to the
HeLa cells that very low doses of 0.0l and 0.001mg/mL were
studied in order to establish an LC-50. The LC-50s were
calculated from least squares regression using the LINEST
function on Microsoft Excel 2000 over the dose response
range or the whole data set in the case of nontoxic extracts to
get a rough quantitative value in order to assess cytotoxicity.
Tris buﬀer, the control, gave an average 92% viability with no
doseresponse.Allvalueswereadjustedupby8%accordingly.
We experienced four general trends in the data. The ﬁrst
two types we labeled “A” for active. The ﬁrst type was a clear
dose-response over the full range of concentrations. Type
two followed a steep dose-response over the initial range of
concentrations while the lower concentrations did not. Type
two was the most cytotoxic. Type three was labeled with an
“M” for mildly active. These showed a weaker dose-response
only at the higher concentrations. Type four was labeled “N”
for not active. These samples showed no dose response and
only marginal mortality. These trends were then evaluated
over medicinal and family lines (Table 1).
4. Discussion and Conclusions
Of the 46 medicinal plant extracts, 54% were active, 26%
were mildly active, and 20% were not active against HeLa
cells. Thus, 80% of the medicinal plant extracts showed
some type of cytotoxicity. This strongly suggests that there
may be some connection between plants known from
indigenous cultures to have medicinal properties compared
to empirically determined cytotoxicity. Our eight non-
medicinalplantsalsotendedtobebioactive,with50%active,
13% mildl, and 37% not active. Only four samples showed
antibacterial activity, which was only in S. aureus, and all
these extracts were from medicinal plants. Thus, only 14%
of the medicinal plants showed limited antibiotic activity.
Asteraceae,thesunﬂowerfamilyandonewiththehighest
medicinal activity rating in Moerman’s paper [3], was the
only family from which we had a fairly large sample, 15
medicinalplants.ExtractsfromAsteraceaetendedtobequite
active and followed the general trends of medicinal plant
bioactivity as stated above with 54% active, 29% mildly
active, and 17% not active. The mint family, Labiateae, also
tended to be cytotoxic with 86% of the plants showing
bioactivity. Because only seven plants were tested, moreJournal of Biomedicine and Biotechnology 3
Table 1: Cytotoxicity of selected plant extracts to bacterial cells and HeLa cancer cells.
Family Genus Species Plant part MD BA HA LC 50
(mg/mL)
m
(slope of the line)
b
(y-intercept) r2
Asteraceae Acanthospermum australe Whole Y N M 0.191 −38.817 57.414 0.112
Asteraceae Ambrosia ambrosioides Areal Y N M −2.199 −13.656 19.970 0.469
Asteraceae Ambrosia ambrosioides Leaf Y N A −2.446 −11.722 21.327 0.412
Asteraceae Ambrosia ambrosioides Stem Y N A 0.466 −152.941 121.230 0.857
Asteraceae Ambrosia ambrosioides Root Y N A 0.439 −124.376 104.617 0.817
Asteraceae Ambrosia deltoidea Stem Y ∗∗ A 0.500 −83.064 91.544 0.293
Asteraceae Hieracium caespitosum Whole Y N M 0.669 −95.238 113.737 0.546
Asteraceae Anaphalis margaritacea Whole N N N 1.195 −51.360 111.373 0.530
Asteraceae Gutierrezia microcephala Areal Y N A 0.470 −143.776 117.641 0.969
Asteraceae Pyrrhopappus carolinianus Whole Y N N 0.117 −1052.510 173.100 0.623
Asteraceae Silphium compositum S/L/Fl/R Y N A 1.388 −49.271 118.400 0.134
Asteraceae Tetragonotheca helianthoides Root Y N A 0.436 −137.978 110.164 0.760
Asteraceae Tetragonotheca helianthoides S/L/Fl/R Y N M 0.357 −157.865 106.395 0.844
Asteraceae Erigeron pumilus Whole Y N A 0.366 −142.337 102.035 0.895
Asteraceae Liatris secunda Whole Y N M 0.531 −156.829 133.257 0.638
Asteraceae Cirsium undulatum Areal Y N M 0.884 −61.281 104.180 0.642
Asteraceae Thelesperma ﬁlifolium Areal Y N A 0.635 −99.503 113.172 0.950
Asteraceae Helianthus nuttallii Stem Y N A 0.539 −135.164 122.791 0.755
Asteraceae Helianthus nuttallii Twig Y N A 0.399 −181.986 122.686 0.944
Asteraceae Haplopappus annuus Whole Y N N 0.918 −77.726 121.359 0.803
Asteraceae Antennaria parvifolia Whole N N A 0.273 −81.056 72.160 0.497
Asteraceae Hymenopappus ﬁlifolius Areal Y N A 0.112 0.167 38.910 0.611
Asteraceae Centaurea maculosa Twig/Fl N N M 0.247 −113.161 77.895 0.863
Asteraceae Scorzonara laciniata Root N N N 1.838 −28.633 102.630 0.188
Boraginaceae Echium candicans Stem Y N M 0.394 −124.333 99.049 0.853
Chenopodiaceae Atriplex confertifolia Areal N N A 0.127 −1116.726 192.195 0.694
Chenopodiaceae Atriplex confertifolia Rhizome N N A 0.317 −142.791 95.259 0.838
Euphorbiaceae Bernardi myicifolia Stem N N A 0.488 −144.404 120.448 0.863
Labiatae Salvia vaseyi Root Y N A 0.105 −1109.581 166.468 0.981
Labiatae Salvia vaseyi Stem Y N A 0.399 −177.100 120.693 0.783
Labiatae Salvia vaseyi Twig/L Y Y A 0.218 −120.339 76.261 0.537
Labiatae Salvia vaseyi Flowers Y N A 0.231 −103.088 73.816 0.589
Labiatae Salvia apiana Root Y Y N 0.112 −1229.526 187.967 0.765
Labiatae Salvia dorrii L/T/FloBu Y N A 0.512 −125.827 114.434 0.852
Labiatae Lavandula stoechas Root/Fl Y N A 0.110 −1069.264 167.838 0.927
Labiatae Lavandula stoechas Stem/L Y N A 0.440 −196.726 136.532 0.804
Labiatae Lycopus asper Stem Y N A 1.043 −39.514 91.202 0.094
Labiatae Marrubium vulgare Areal Y N A 0.241 −112.266 77.093 0.768
Labiatae Satureja douglasii Whole Y N A 0.293 −102.001 79.891 0.665
Malvaceae Sphaeralcea angustifolia Whole N N A 0.304 −129.152 89.243 0.658
Pinaceae Pinus monticola Bark/St Y Y A 0.346 −175.851 110.896 0.764
Pinaceae Pinus monticola Twig/L Y N M 0.438 −78.452 84.370 0.396
Pinaceae Pinus monticola Root Y N A 0.573 −95.050 104.422 0.606
Pinaceae Picea sitchensis Root Y N N 0.496 −125.394 112.182 0.847
Pinaceae Picea sitchensis Stem Y N M 0.583 −118.928 119.326 0.562
Pinaceae Picea sitchensis Bark Y N M 0.366 −134.091 99.034 0.684
Pinaceae Picea sitchensis Twig/L Y N N 0.526 −121.778 114.038 0.835
Pinaceae Picea sitchensis Cone Y N A 0.438 −59.520 76.046 0.326
Pinaceae Abies procera Root N Y N 0.381 −155.741 109.290 0.9784 Journal of Biomedicine and Biotechnology
Table 1: Continued.
Family Genus Species Plant part MD BA HA LC 50
(mg/mL)
m
(slope of the line)
b
(y-intercept) r2
Ranunculaceae Delphinium geyeri Areal Y N M 1.306 −29.140 88.057 0.173
Ranunculaceae Aquilegia fromosa Root Y N M 1.532 −25.856 89.605 0.222
Ranunculaceae Aquilegia fromosa Flowers Y N N 0.612 −82.675 100.574 0.534
Ranunculaceae Aquilegia fromosa Leaf Y N N 0.521 −143.711 124.894 0.784
Ranunculaceae Delphinium glareosum Whole Y N N 0.824 −91.704 125.548 0.428
Ranunculaceae Delphinium nuttallianum Areal Y N N 1.319 −35.840 97.287 0.350
MD: medicinal plant; Y: medicinal plant; N: non-medicinal plant
BA: bacterial assay; Y: inhibition; N: no inhibition; ∗∗sample lost
H A :H e L ac e l la s s a y ;A :a c t i v e ;M :m i l d l ya c t i v e ;N :n o ta c t i v e
Plant part; S/St: stem Fl: ﬂower; FloBu: ﬂowering bush; A: areal R: root; L: leaf; T: twig.
data should be collected from this family before a general
conclusion can be made about its cytotoxicity. Of the
nine Pinaceae plant extracts, 67% showed some bioactivity.
Additional work is needed to determine which plant parts
tend to have the highest bioactivity. The least active of our
ﬁve medicinal families was Ranunculaceae with two out
of six plant extracts (33%) showing mild activity. Overall
these data clearly suggest that non-medicinal as well as so-
calledmedicinalplantsshouldbeusedingeneralcytotoxicity
screening evaluations. In fact, de Oliveira Maria et al. [4]
also found signiﬁcant bioactivity in 12 species of Amazonian
plants which were non-medicinal.
Though this work proved to be insightful, future studies
should be undertaken in order to get a clearer picture of
the evolutionary relationship of bioactivity and medicinal
ranking of plants. From the literature, it appears that only
three plants from our group, Ambrosia ambrosioides [5, 6],
Gutierrezia microcephala [7], and Atriplex confertifolia [8]
have had extensive research on their cytotoxicity. Hence,
there is a great deal of toxicology work yet to be done on
the remainder of the plants shown to be bioactive in our
investigation.
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